Table 3.
Clinical signs of IPA patients with CLIF lung score ≤ 1 or CLIF lung score > 1
| SOFA lung score ≤ 1 (n = 83) | SOFA lung score > 1 (n = 62) | p value | |
|---|---|---|---|
| Number | 83 | 62 | |
| Age in years, mean (SD) | 44.31 (11.69%) | 50.05 (13.38%) | 0.010 |
| Signs and symptoms | |||
| Refractory fever | 31 (37.3%) | 36 (58.1%) | 0.022 |
| Recrudescent fever | 17 (20.5%) | 19 (30.6%) | 0.182 |
| Pleuritic chest pain | 3 (3.6%) | 1 (1.6%) | 0.791 |
| Pleuritic rub | 5 (6.0%) | 10 (16.1%) | 0.057 |
| Dyspnea | 30 (36.1%) | 38 (61.3%) | 0.005* |
| Hemoptysis | 12 (14.5%) | 20 (32.3%) | 0.015* |
| Worsening respiratory insufficiency | 22 (26.5%) | 34 (54.8%) | 0.001* |
p value from Pearson’s v2 test or Fisher’s exact test in univariate analysis
BW body weight, HBV hepatitis B virus, EASL-CLIF European Association for the Study of the Liver- Chronic Liver Failure consortium, SOFA sequential organ failure assessment score, Refractory fever fever refractory to at least 3 d of appropriate antibiotic therapy, Recrudescent fever recrudescent fever after a period of defervescence of at least 48 h while still on antibiotics and without other apparent cause, Worsening respiratory insufficiency worsening respiratory insufficiency in spite of appropriate antibiotic therapy and ventilatory support
*p values are statistically significant